202 related articles for article (PubMed ID: 29779047)
1. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
2. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
[TBL] [Abstract][Full Text] [Related]
3. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.
Koh JM; Ahn SH; Kim H; Kim BJ; Sung TY; Kim YH; Hong SJ; Song DE; Lee SH
PLoS One; 2017; 12(11):e0187398. PubMed ID: 29117221
[TBL] [Abstract][Full Text] [Related]
4. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
6. Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior.
Stenman A; Svahn F; Hojjat-Farsangi M; Zedenius J; Söderkvist P; Gimm O; Larsson C; Juhlin CC
Am J Surg Pathol; 2019 Mar; 43(3):409-421. PubMed ID: 30451732
[TBL] [Abstract][Full Text] [Related]
7. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates.
Diaz-Cano SJ; de Miguel M; Blanes A; Tashjian R; Galera H; Wolfe HJ
J Pathol; 2000 Oct; 192(2):221-8. PubMed ID: 11004699
[TBL] [Abstract][Full Text] [Related]
8. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
Guo Z; Lloyd RV
Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
[TBL] [Abstract][Full Text] [Related]
10. The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature.
Stenman A; Zedenius J; Juhlin CC
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30769931
[TBL] [Abstract][Full Text] [Related]
11. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
Juhlin CC
Endocr Pathol; 2021 Jun; 32(2):228-244. PubMed ID: 33768452
[TBL] [Abstract][Full Text] [Related]
12. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Breza J; Breza J
Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
Stenman A; Svahn F; Welander J; Gustavson B; Söderkvist P; Gimm O; Juhlin CC
Endocr Pathol; 2015 Mar; 26(1):9-14. PubMed ID: 25403449
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of morphology of adrenal pheochromocytoma as regards their potential malignancy].
Kajor M; Ziaja J; Lange D; Król R; Ciupińska-Kajor M; Turska-d'Amico M; Maka B; Cierpka L
Endokrynol Pol; 2005; 56(6):911-6. PubMed ID: 16821210
[TBL] [Abstract][Full Text] [Related]
16. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
Stenman A; Zedenius J; Juhlin CC
Surgery; 2019 Nov; 166(5):901-906. PubMed ID: 31239074
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
Ospina NS; Maraka S; Donegan D; Morris JC
Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
Quayle FJ; Fialkowski EA; Benveniste R; Moley JF
Surgery; 2007 Dec; 142(6):800-5; discussion 805.e1. PubMed ID: 18063059
[TBL] [Abstract][Full Text] [Related]
19. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
